Dekorationsartikel gehören nicht zum Leistungsumfang.
Sprache:
Englisch
47,95 €
UVP 53,49 €
Versandkostenfrei per Post / DHL
Lieferzeit 1-2 Wochen
Kategorien:
Beschreibung
This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets.
This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets.
Über den Autor
Previous publications in the Handbook of Experimental Pharmacology series co-edited by Prof. ¿Arnold von Eckardstein : Atherosclerosis: Diet and Drugs, 2005, Arnold von Eckardstein; High Density Lipoproteins, 2015, Arnold von Eckardstein, Dimitris Kardassis (eds.), Open Access
Zusammenfassung
Summarizes the latest studies on the management of cardiovascular risk factors
Reviews exhaustively the key recent research into the pathogenesis of atherosclerotic cardiovascular diseases
Outlines various strategies of identifying and validating novel targets for prevention and treatment of atherosclerosis
This book is open access, which means that you have free and unlimited access
Inhaltsverzeichnis
Diet, Life Style, Smoking.- Blood Pressure Lowering.- Glycemic Control in Diabetes.- LDL-Cholesterol Lowering.- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation).- Triglyceride Rich Lipoproteins.- HDL.- Lipoprotein(a).- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome.- Nutraceuticals / Functional Food.- Adipose Tissue (WAT, BAT).- Microbiota and Cardiometabolic Disease.- SMCs, Matrix.- Immune Modulation.- NETs and Neutrophils.- Genomic Strategies Towards Identification of Novel Therapeutic Targets.- Non Coding RNAs.- Metabolomics, Lipidomics.- Epigenomics.
Details
Erscheinungsjahr: | 2022 |
---|---|
Fachbereich: | Andere Fachgebiete |
Genre: | Mathematik, Medizin, Naturwissenschaften, Technik |
Rubrik: | Wissenschaften |
Medium: | Buch |
Inhalt: |
x
538 S. 3 s/w Illustr. 37 farbige Illustr. 538 p. 40 illus. 37 illus. in color. |
ISBN-13: | 9783030860752 |
ISBN-10: | 3030860752 |
Sprache: | Englisch |
Einband: | Gebunden |
Redaktion: |
Binder, Christoph J.
Eckardstein, Arnold von |
Herausgeber: | Arnold von Eckardstein/Christoph J Binder |
Auflage: | 1st edition 2022 |
Hersteller: | Springer International Publishing |
Verantwortliche Person für die EU: | Springer Verlag GmbH, Tiergartenstr. 17, D-69121 Heidelberg, juergen.hartmann@springer.com |
Maße: | 241 x 160 x 33 mm |
Von/Mit: | Christoph J. Binder (u. a.) |
Erscheinungsdatum: | 01.02.2022 |
Gewicht: | 1,08 kg |